- Poster presentation
- Open Access
Identification of mutations in DYNC2LI1, a member of the mammalian cytoplasmic dynein 2 complex, expands the clinical spectrum of Jeune/ATD ciliopathies
© Kessler et al. 2015
Published: 13 July 2015
Ciliopathies are caused by defects in formation, maintenance and function of the primary cilium and underlying genes affect the dynein motor, intraflagellar transport complexes, or the basal body. In a patient of non-consanguineous parents presenting an intermediate phenotype between asphyxiating thoracic dystrophy and Ellis-van Crefeld syndrome we performed exome sequencing. Variants were selected based on potential ciliary function as identified in a yeast two-hybrid screen with NEK1, a basal body protein involved in short rib-polydactyly type Majeweski (SRPSII). We identified compound heterozygous nonsense (p.R208X) and missense (p.T221I) mutations in DYNC2LI1 segregating in the family. DYNC2LI1 is ubiquitously expressed and interacts with DYNC2H1 to form the dynein 2 complex important for retrograde intraflagellar transport. The hypothetical protein caused by the nonsense mutation lacks the coiled-coil domain involved in protein interaction and dimerization. The mutation p.T221I affects a highly conserved nucleoside triphosphate hydrolase domain responsible for GTPase driven dynein protein localization. Mutations in both DYNC2LI1 interacting partners DYNC2H1 and NEK1 are associated with ATD and SRPSs. We screened further patients of our short stature cohort and identified in two siblings heterozygous mutations in DYNC2LI1 (p.M1T) and its interaction partner DYNC2H1 (p.K495T). The DYNC2H1 mutation was previously reported by El Hokayem et al. compound heterozygous with a splice site mutation in a patient with SRPSII. Our results might indicate a possible digenic diallelic inheritance in our patients. This is the first report of mutations in DYNC2LI1 as part of the dynein 2 complex further expanding the clinical spectrum of ciliopathies.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.